The Pharma Data

OCTOBER 27, 2020

.” The single-reaction panel targets five regions of the viral genome and provides excellent accuracy and sensitivity. “Most real time qPCR-based assays target only two or three targets on the viral genome.” “Most real time qPCR-based assays target only two or three targets on the viral genome.”

Genetic Analysis 52

Genetic Analysis Genome Genomics Reagent 52

XTalks

AUGUST 18, 2020

Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. This is significant because shortages of RNA extraction kits have been a recurrent issue since the beginning of the pandemic.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Roots Analysis

FEBRUARY 23, 2022

Over the past few years, several companies have started offering a diverse range of genome sequencing products and services using various second and third generation sequencing technologies. NGS Library Preparation Kits Market. Likely Growth of the NGS Library Preparation Kits Market. Strong Intellectual Property Portfolio.

Genetics 52

Genetics DNA RNA Reagent 52

Pharmaceutical Technology

FEBRUARY 15, 2023

Outlook The era of mRNA-based genomic medicines is on the horizon. PNI’s GenVoy Delivery Platform comprises off-the-shelf RUO reagents such as GenVoy-ILM and a library of proprietary lipids available as custom formulations. The technology underpinning the COVID-19 vaccines are the tip of the iceberg.

Bioassay 130

Bioassay RNA Development Drugs 130

The Pharma Data

DECEMBER 2, 2020

ERS Genomics – Ireland’s ERS Genomics Limited, and Germany’s Vivlion GmbH, announced a non-exclusive license agreement granting Vivlion access to ERS Genomics’ CRISPR/Cas9 patent portfolio, to enhance Vivlion’s gene editing reagents and screening services. Financial details of the agreement were not disclosed.

Drugs 52

Drugs Gene Editing Genome Genomics 52

The Pharma Data

OCTOBER 14, 2020

They offer access to an intact genome which allows whole genome sequencing without a background. About Savran Tech’s Market Applications. 2) Prenatal Diagnostics : circulating throphoblasts in maternal blood can provide a comprehensive, non-invasive picture of a fetus as well as access to an intact genome.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Genome 40

The Pharma Data

OCTOBER 14, 2020

ERS Genomics – Ireland’s ERS Genomics signed an agreement with FASMAC Co., Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it. The funds will be used to bring Ori’s innovative manufacturing platform to the market.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing In-Vivo 52

The Pharma Data

JANUARY 20, 2021

Laboratory Implementation Laboratory reagents for performing the test commercially have been designed and are currently being validated in preparation for regulatory submission to CMS/CLIA with a view to targeting sales in the USA initially. MELBOURNE, Australia, Jan.

Genetics 40

Genetics Reagent Biobanking Production 40

XTalks

JANUARY 6, 2025

Additionally, CRISPR genome-wide screening holds great potential for identifying key disease-associated genes and uncovering novel therapeutic targets. The global market for cell and gene therapies , valued at $5.9 The market for molecular diagnostics was valued at $25 billion in 2022 and is projected to grow at a CAGR of over 3.5

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111

Roots Analysis

JANUARY 27, 2025

The recent advancements in the field of protein expression, coupled with the launch of novel expression systems have emerged as the key drivers for the growing adoption of protein expression solutions in the overall pharma market. Want additional details on the market? Access our Protein Expression Market Report.

Protein 40

Protein Reagent Marketing Gene 40